Dropbox Inc vs Novavax Inc — how do they compare? Dropbox Inc trades at $33.51 (market cap $7.41B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: Dropbox Inc is far larger — about 5.7× Novavax Inc's market cap, and Dropbox Inc is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| DBX | NVAX | |
|---|---|---|
Market Cap | $7.41B | $1.31B |
Sector | Technology | Health |
52-Week High | $35.00 | $11.19 |
52-Week Low | $22.06 | $6.22 |
Enterprise Value | $10.27B | $889.30M |
Trailing returns across standard periods
Latest headlines on both assets
Dropbox is a leading provider of cloud-storage and content collaboration tools with an emphasis on individuals and SMB. The company was founded in 2007 and was a pioneer in cloud storage and cross-platform file syncing. Utilizing inorganic and organic means, the firm has been working on diversifying its product mix and pivoting away from the cloud-storage space.
Read more on DBX →Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →